DEC 28, 2020 9:00 AM PST

Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells

WRITTEN BY: Annie Lennon

Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and adults. As such, new ways to tackle the disease are urgently needed. Now, researchers from Goethe University in Germany have found that Loperamide, an anti-diarrhea medication, can induce cell death in these cancer cells. 

Early research suggests that the drug works via a mechanism known as autophagy-dependent cell death. Autophagy is a cellular mechanism that regulates metabolic processes and allows the recycling or orderly breakdown of cellular components to ensure the cell’s survival. Autophagy-dependent cell death works by disrupting this process in cells in such a way that they can no longer survive. 

In their experiments, the researchers found that Loperamide leads to a stress response in the endoplasmic reticulum (ER)- a cell organelle key for protein synthesis in the body. This stress leads to degradation and then self-destruction of cells. In particular, they found that the drug and ER stress response both increase levels of a factor known as ‘Activating Transcription Factor’ (ATF4), which triggers the destruction of ER membranes and the ER. 

 

To test its relevance in the drug mechanism, they tried blocking it. In doing so, they noted that far fewer cells in tumor cell cultures died, even after adding Loperamide, thus suggesting it to be a key part of the drug mechanism. 

The researchers also found that the drug only triggers autophagy, and not cell death, in other cells too, including embryonic mouse fibroblasts. This follows on from its usage as an antidiarrheal treatment, where it binds to specific sites in the intestine but is not absorbed by the bowel, thus making it largely harmless. 

The researchers say that their findings could help develop new therapeutics for glioblastoma, as well as other conditions where ER degradation is disrupted, such as dementia and other types of tumor. Before this may be the case, however, further studies are needed to investigate, for example, how Loperamide may be transported across the blood-brain barrier and to the brain. 

 

Sources: Neuroscience NewsAutophagy

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
AUG 08, 2021
Drug Discovery & Development
Dietary Supplements Treat Genetic Cause of PTSD
AUG 08, 2021
Dietary Supplements Treat Genetic Cause of PTSD
A combination of two natural nutritional supplements, vitamin A and methyl donor S-adenosylmethionine (SAM), can treat P ...
AUG 21, 2021
Coronavirus
The Molecular Gate That Enables SARS-CoV-2 to Infect Cells
AUG 21, 2021
The Molecular Gate That Enables SARS-CoV-2 to Infect Cells
Researchers investigating how the SARS-CoV-2 virus gets into cells to cause COVID-19 learned early on in the pandemic th ...
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
SEP 23, 2021
Technology
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
SEP 23, 2021
New Glaucoma Drainage Implant Safe And Effective At Reducing Intraocular Pressure
Glaucoma, which affects an estimated 57 million people worldwide, is an eye condition caused by too much pressure around ...
OCT 04, 2021
Genetics & Genomics
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
OCT 04, 2021
Zaki syndrome - Pediatric Disorder & Potential Treatment ID'ed
Since it's become quick and relatively inexpensive to sequence a human genome, researchers have gained unprecedented and ...
OCT 14, 2021
Drug Discovery & Development
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
OCT 14, 2021
Itchy, red, dry eyes? FDA approves monthly implant for allergic conjunctivitis
The conjunctiva is a thin membrane that covers the front of the eyes and the inner eyelids. The conjunctiva produces tea ...
Loading Comments...